Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
about
beta-Amyloid degradation and Alzheimer's diseaseEndothelin-converting enzymes and related metalloproteases in Alzheimer's diseaseGender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease.Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assayGenetic architecture of epigenetic and neuronal ageing rates in human brain regions.Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolismRegulation of vascular contractility and blood pressure by the E2F2 transcription factor.Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer's Disease.Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.Protein kinase C-regulated aβ production and clearance.Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats.Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.
P2860
Q21284467-0CB60EAC-8730-4961-AAD2-B42ADEA3787BQ26862901-CA233408-43B5-4E67-B6D3-2016499C5838Q33427814-A58316EF-FD9F-4E4D-8665-2817C7AD9DB4Q33642530-8DF12A22-40AC-4BCB-A9B1-8F1D20F75660Q33679572-13619B76-34EA-4870-A695-3359DA630774Q33753774-13276607-5EF7-4250-8115-C8FC41BD215BQ34130147-D092CEFB-7CB6-4B96-8120-D530BC298CA6Q34650321-19335A2A-15DA-4027-86C1-F5038930C7F7Q35838756-FC5E7EBB-FCC7-4936-816A-AB69AE0787C7Q37445515-1C5A8689-1657-435F-919A-507A4BA2F0BEQ38859874-A404EFB2-17CA-4E70-91DF-E08F8CF98500Q38955319-3AC70F84-0BA8-409D-ADC9-6098DDB60C4AQ41680485-2C5ED8B2-9FE1-4735-88ED-60B39BC755AAQ41869540-79C2D692-9FC9-4725-BB4D-2A0596894F7EQ48226763-B434CAFF-81C3-4BE2-9C49-5C43B81DD776Q48301166-01B89862-9ABA-46C0-8694-8BE30A0C9E8AQ53329467-D4204A26-6DB8-4E8D-83A5-863D6F9DE3E2
P2860
Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@en
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@nl
type
label
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@en
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@nl
prefLabel
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@en
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@nl
P2093
P2860
P356
P1433
P1476
Endothelin-converting enzyme-1 ...... s against Alzheimer's disease.
@en
P2093
A Claperon
A Delacourte
J Epelbaum
J-C Schwartz
N Helbecque
P2860
P2888
P304
1122-8, 1059
P356
10.1038/SJ.MP.4001584
P407
P577
2004-12-01T00:00:00Z
P5875
P6179
1026715081